Emerald Rebalances Tech
Emerald Funds Trim Holdings in Key Tech Stocks as Part of Broader Portfolio Rebalancing
Anonymous
Key Points
1
In WAVE Life Sciences, while Emerald Mutual Fund Advisers Trust trimmed its stake by 42.4% to 814,529 shares, Pictet Asset Management Holding SA boosted its position by purchasing 343,226 additional shares for a total of 1,149,127 shares worth about $8.202 million.
2
In Synaptics, insider Vikram Gupta sold 692 shares on May 26 at an average price of $147.50 for a total of $102,070, leaving Gupta with 83,434 shares valued at roughly $12.31 million.
3
SiTime attracted multiple institutional moves in the first quarter, including Royal Bank of Canada increasing to 4,411 shares ($675,000), Advisors Asset Management boosting to 350 shares ($54,000), AQR Capital Management rising to 10,754 shares ($1.557 million), and Intech Investment Management increasing to 8,322 shares ($1.272 million).
4
Onto Innovation observed broad hedge-fund activity beyond Emerald’s 3.4% cut to 118,423 shares, with Parallel Advisors, Kestra Advisory Services, Root Financial Partners, Smartleaf Asset Management, and Millstone Evans Group expanding stakes; moreover, about 98.35% of Onto’s stock is owned by hedge funds and institutional investors.
5
Emerald Advisers LLC’s Rambus stake remains a sizable holding, representing roughly 1.3% of its portfolio and ranking as Emerald’s 17th largest position, even after a 21.3% reduction to 493,236 shares valued at about $42.43 million.
Emerald Mutual Fund Advisers Trust and its affiliate Emerald Advisers LLC have been quietly pruning their tech portfolios. The firms trimmed positions across five semiconductor and biotech names in the first quarter, according to Watchlist News, cutting stakes by as much as 42.4% in some cases.
The moves span companies ranging from WAVE Life Sciences to Rambus. Together, they signal a broad rebalancing effort by Emerald across its tech-focused holdings.
Emerald Slashes WAVE Life Sciences Stake by 42%
The biggest cut came in WAVE Life Sciences. Emerald Mutual Fund Advisers Trust sold enough shares to reduce its position by 42.4%, leaving it with 814,529 shares worth about $5.9 million, according to Watchlist News. That is a sharp pullback from its earlier exposure to the biotech firm.
Not everyone is retreating, though. Pictet Asset Management Holding SA moved in the opposite direction. It bought 343,226 additional shares, bringing its total to 1,149,127 shares valued at roughly $8.2 million. That makes Pictet one of the stock's larger institutional holders.
Synaptics and SiTime See Mixed Institutional Moves
Emerald Advisers LLC cut its Synaptics stake by 2.7%, bringing its holding to 329,916 shares worth about $23.1 million, per Watchlist News. At the same time, insider Vikram Gupta sold 692 Synaptics shares on May 26 at $147.50 each, collecting $102,070. After the sale, Gupta still holds 83,434 shares valued at roughly $12.3 million.
SiTime drew more varied activity. Emerald Mutual Fund Advisers Trust cut its position by 22.1% to 41,170 shares, valued at about $14.2 million. But several other firms bought in. Royal Bank of Canada increased to 4,411 shares ($675,000). AQR Capital Management grew its stake to 10,754 shares ($1.6 million). Intech Investment Management lifted its position to 8,322 shares ($1.3 million), according to Watchlist News.
Onto Innovation Remains Dominated by Institutional Owners
Emerald Advisers LLC trimmed its Onto Innovation stake by 3.4%, settling at 118,423 shares worth about $24.3 million. But the broader picture shows heavy institutional interest. About 98.35% of Onto Innovation's stock is owned by hedge funds and institutional investors, per Watchlist News.
Several firms actually expanded their Onto positions. Parallel Advisors, Kestra Advisory Services, Root Financial Partners, Smartleaf Asset Management, and Millstone Evans Group all grew their stakes. Emerald's trim looks modest against that backdrop of broader institutional buying.
Rambus Cut Leaves Emerald With $42 Million Position
Emerald Advisers LLC reduced its Rambus stake by 21.3%, leaving it with 493,236 shares worth about $42.4 million, according to Ticker Report. That is still a sizable bet. Rambus ranks as Emerald's 17th largest holding and makes up roughly 1.3% of its total portfolio.
A separate Emerald entity, Emerald Mutual Fund Advisers Trust, also sold Rambus shares — cutting its position by 21.5% to 307,248 shares. The parallel cuts across both Emerald arms suggest a coordinated decision to reduce exposure to the semiconductor IP company.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
18
Articles
15
Reach
33
A
AnonymousAuthor